We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

88 hedge funds and large institutions have $35.2M invested in Chinook Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 97 → 88 (-9)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

34% less capital invested

Capital invested by funds: $53.6M → $35.2M (-$18.4M)

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
88
Holders Change
-9
Holders Change %
-9.28%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
26
Reduced
30
Closed
18
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$65K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.34M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.23M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$714K
4
EAM
Erste Asset Management
Austria
+$258K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$256K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$2.71M
2
FLAM
First Light Asset Management
Minnesota
-$1.49M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$381K
4
ClearBridge Investments
ClearBridge Investments
New York
-$341K
5
Goldman Sachs
Goldman Sachs
New York
-$282K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$5.62M +$95.3K +14,354 +1%
Baillie Gifford & Co
2
Baillie Gifford & Co
United Kingdom
$4.37M +$74K +11,146 +1%
Renaissance Technologies
3
Renaissance Technologies
New York
$2.9M +$1.23M +185,200 +51%
FLAM
4
First Light Asset Management
Minnesota
$2.65M -$1.49M -224,127 -31%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.36M -$381K -57,412 -11%
JP Morgan Chase
6
JP Morgan Chase
New York
$1.55M +$62K +9,337 +3%
EAM
7
Erste Asset Management
Austria
$1.37M +$258K +38,800 +18%
State Street
8
State Street
Massachusetts
$1.36M +$73.4K +11,060 +4%
AQR Capital Management
9
AQR Capital Management
Connecticut
$1.31M +$714K +107,618 +77%
BI
10
BVF Inc
California
$1.07M +$1.34M +202,000 New
AG
11
Artal Group
Luxembourg
$1.06M – – –
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$810K -$123K -18,568 -11%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$808K +$2.93K +441 +0.3%
Northern Trust
14
Northern Trust
Illinois
$775K -$38.8K -5,841 -4%
PAM
15
Panagora Asset Management
Massachusetts
$730K +$6.07K +914 +0.7%
HMC
16
Harvard Management Company
Massachusetts
$679K – – –
Assenagon Asset Management
17
Assenagon Asset Management
Luxembourg
$447K -$159K -23,985 -22%
BCM
18
Bridgeway Capital Management
Texas
$369K – – –
OAM
19
Oxford Asset Management
United Kingdom
$353K -$186K -28,078 -30%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$335K +$113K +17,087 +37%
Two Sigma Investments
21
Two Sigma Investments
New York
$319K -$6.23K -939 -2%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$295K +$24.2K +3,640 +7%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$271K +$206K +31,049 +154%
Axa
24
Axa
France
$260K -$13.1K -1,980 -4%
CS
25
Candriam SCA
Luxembourg
$253K – – –
1
2 3 4 5

KDNY Hedge Fund Activity: Q3 2019 in Review

88 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q3 2019, worth a combined $35.2M — down 34% from $53.6M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of KDNY and 9 opened new positions — a net loss of 9 holders — while 30 trimmed existing stakes and 26 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $1.34M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $2.71M sold.

  • 88 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q3 2019, down from 97 in Q2 2019.
  • Funds reported $35.2M of Chinook Therapeutics, Inc. Common Stock stock for Q3 2019, down 34% quarter-over-quarter.
  • 9 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q3 2019 and 18 closed out, a net change of -9 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q3 2019 was BVF Inc, an estimated $1.34M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q3 2019 was EcoR1 Capital, an estimated $2.71M sold.

Based on aggregated 13F filings for Q3 2019.